Laurus Labs

Leading Indian pharmaceutical manufacturer specializing in APIs and CDMO services. Expanding into peptide manufacturing. USFDA-inspected facilities. Integrated API development from R&D to commercial scale. Present at CPHI showcasing peptide capabilities.

Laurus Labs is listed as a CDMO in the peptide supply chain, serving Asia markets from India (Hyderabad). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.